HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aysegul A Sahin Selected Research

Aysegul A Sahin Research Topics

Disease

110Breast Neoplasms (Breast Cancer)
09/2022 - 01/2002
86Neoplasms (Cancer)
09/2022 - 01/2002
21Neoplasm Metastasis (Metastasis)
10/2019 - 05/2002
11Carcinoma (Carcinomatosis)
09/2022 - 01/2002
10Pathologic Complete Response
02/2017 - 06/2005
9Triple Negative Breast Neoplasms
04/2021 - 01/2013
5Carcinogenesis
01/2019 - 08/2002
4Noninfiltrating Intraductal Carcinoma (DCIS)
09/2015 - 06/2002
3Lobular Carcinoma
11/2021 - 01/2002
3Lymphatic Metastasis
10/2018 - 04/2009
3Genetic Predisposition to Disease (Genetic Predisposition)
04/2013 - 02/2002
2Adenocarcinoma
12/2016 - 06/2005
2Brain Neoplasms (Brain Tumor)
05/2015 - 09/2013
2Inflammation (Inflammations)
04/2013 - 08/2007
2Neoplasm Micrometastasis
06/2009 - 09/2003
2Inflammatory Breast Neoplasms
10/2008 - 07/2007
2Margins of Excision
10/2008 - 07/2005
2Disease Progression
11/2004 - 05/2004
1Extramammary Paget Disease (Paget Disease, Extramammary)
05/2019

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
12/2016 - 03/2002
18Estrogen ReceptorsIBA
01/2022 - 04/2002
13Biomarkers (Surrogate Marker)IBA
04/2021 - 06/2002
11Trastuzumab (Herceptin)FDA Link
11/2018 - 08/2003
10Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 04/2002
9Messenger RNA (mRNA)IBA
01/2021 - 03/2002
9Hormones (Hormone)IBA
10/2018 - 01/2004
9Doxorubicin (Adriamycin)FDA LinkGeneric
03/2010 - 06/2002
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2010 - 06/2002
7Fluorouracil (Carac)FDA LinkGeneric
03/2010 - 06/2002
6ErbB Receptors (EGF Receptor)IBA
11/2021 - 05/2003
6human ERBB2 proteinIBA
11/2021 - 06/2005
6LigandsIBA
05/2019 - 03/2002
6Paclitaxel (Taxol)FDA LinkGeneric
03/2015 - 03/2003
5Pharmaceutical PreparationsIBA
12/2018 - 02/2002
5Epidermal Growth Factor (EGF)IBA
12/2018 - 03/2002
5ParaffinIBA
10/2016 - 09/2003
5Estrogens (Estrogen)FDA Link
01/2016 - 03/2002
4Phosphotransferases (Kinase)IBA
04/2021 - 12/2003
4CytokinesIBA
12/2016 - 05/2002
4Cyclin D1IBA
12/2016 - 09/2003
4TamoxifenFDA LinkGeneric
09/2014 - 02/2003
4AnthracyclinesIBA
05/2012 - 06/2002
4Docetaxel (Taxotere)FDA Link
05/2012 - 01/2003
3Phenobarbital (Luminal)FDA Link
09/2022 - 10/2016
3Cyclin EIBA
04/2021 - 01/2016
3Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 10/2002
3Peptides (Polypeptides)IBA
01/2019 - 05/2002
3Formaldehyde (Formol)FDA Link
10/2016 - 09/2003
3Biological ProductsIBA
06/2009 - 10/2002
3Transcription Factors (Transcription Factor)IBA
12/2005 - 08/2003
3NF-kappa B (NF-kB)IBA
12/2005 - 11/2003
3DNA AdductsIBA
09/2003 - 02/2002
2Immune Checkpoint InhibitorsIBA
05/2019 - 01/2019
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2016 - 08/2007
2RNA (Ribonucleic Acid)IBA
09/2015 - 12/2002
2Indicators and Reagents (Reagents)IBA
10/2014 - 01/2004
2Hematoxylin (Haematoxylon)IBA
10/2014 - 04/2005
2Eosine Yellowish-(YS) (Eosin)IBA
10/2014 - 04/2005
2src-Family KinasesIBA
09/2013 - 08/2005
2DNA (Deoxyribonucleic Acid)IBA
04/2013 - 01/2004
2Estrogen Receptor alphaIBA
05/2010 - 03/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2007 - 08/2002
2Epirubicin (Ellence)FDA LinkGeneric
01/2007 - 06/2005
2Protein Glutamine gamma Glutamyltransferase 2IBA
09/2005 - 12/2004
2Complementary DNA (cDNA)IBA
09/2005 - 05/2004
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2005 - 12/2002
2Carrier Proteins (Binding Protein)IBA
11/2003 - 03/2002
2Neuregulin-1 (Neuregulin 1)IBA
05/2003 - 03/2002
2histidine-rich proteinsIBA
05/2003 - 03/2002
2CarcinogensIBA
08/2002 - 02/2002
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2002 - 03/2002
1Granzymes (Granzyme)IBA
01/2022
1Cytotoxins (Cytolysins)IBA
09/2021
1dinutuximabIBA
01/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2019
1Nucleic AcidsIBA
01/2019
1safingol (sphinganine)IBA
01/2019
1Long Noncoding RNAIBA
01/2019
1Ligases (Synthetase)IBA
01/2019
1sphingosine kinaseIBA
01/2019
1Histones (Histone)IBA
01/2019
1AntigensIBA
01/2019
1Bortezomib (Velcade)FDA Link
01/2019
1Programmed Cell Death 1 ReceptorIBA
12/2018
1TransferasesIBA
12/2018
1B7-H1 AntigenIBA
12/2018
1N-acetyltalosaminuronic acid (NAT)IBA
11/2018
1CurcuminIBA
12/2016
1Lactoglobulins (beta-Lactoglobulin)FDA Link
12/2016
1Aurora Kinase AIBA
12/2016
1Biological FactorsIBA
07/2016

Therapy/Procedure

34Therapeutics
09/2021 - 10/2002
27Neoadjuvant Therapy
11/2021 - 06/2002
24Drug Therapy (Chemotherapy)
01/2021 - 06/2002
10Radiotherapy
10/2018 - 07/2002
6Segmental Mastectomy (Lumpectomy)
06/2019 - 09/2003
6Mastectomy (Mammectomy)
01/2013 - 07/2002
3Adjuvant Chemotherapy
03/2010 - 07/2002
2Aftercare (After-Treatment)
07/2016 - 11/2002
1Immunotherapy
01/2019